These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 2855863)

  • 1. [The central effect of calcium antagonists].
    Siembab D; Janicki PK; Rewerski W
    Pol Tyg Lek; 1988 Dec 19-26; 43(51-52):1676-8. PubMed ID: 2855863
    [No Abstract]   [Full Text] [Related]  

  • 2. Calcium channels and calcium channel blockers.
    Seth SD; Seth S
    Indian J Physiol Pharmacol; 1991 Oct; 35(4):217-31. PubMed ID: 1667398
    [No Abstract]   [Full Text] [Related]  

  • 3. [Importance of calcium ions and calcium antagonists in affective psychoses].
    Walden J; Grunze H; Olbrich H; Berger M
    Fortschr Neurol Psychiatr; 1992 Dec; 60(12):471-6. PubMed ID: 1337539
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [The role of Ca2+ in the pathogenesis of epilepsy. Calcium antagonists--a new class of anticonvulsants].
    Glebov RN; Karpova MN
    Patol Fiziol Eksp Ter; 1990; (3):57-61. PubMed ID: 2169039
    [No Abstract]   [Full Text] [Related]  

  • 5. [Calcium antagonists: recent developments].
    Wibo M
    J Pharm Belg; 1995; 50(1):27-33. PubMed ID: 7602448
    [No Abstract]   [Full Text] [Related]  

  • 6. Basis for the application of calcium antagonists in neurology. Florence, May 25-27, 1989. Proceedings.
    Eur Neurol; 1990; 30 Suppl 2():1-41. PubMed ID: 2318231
    [No Abstract]   [Full Text] [Related]  

  • 7. [Calcium channel blocking--its use in pathophysiological studies and in the treatment of diseases of the nervous system].
    Głabiński A
    Postepy Hig Med Dosw; 1991; 45(3-4):233-44. PubMed ID: 1946093
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Current and potential indications for Ca2+ antagonists.
    Scriabine A
    Ration Drug Ther; 1987 Nov; 21(11):1-7. PubMed ID: 3328218
    [No Abstract]   [Full Text] [Related]  

  • 9. Aluminium related changes in brain histology: protection by calcium and nifedipine.
    Basu S; Das Gupta R; Chaudhuri AN
    Indian J Exp Biol; 2000 Sep; 38(9):948-50. PubMed ID: 12561958
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Neuroanatomic and neurophysiologic changes in the aging brain.
    Kelly KM
    Geriatrics; 2005 May; Suppl():4-6, 19. PubMed ID: 16025881
    [No Abstract]   [Full Text] [Related]  

  • 11. [The comparative characteristics of calcium channel blockers].
    Maĭskiĭ VV
    Eksp Klin Farmakol; 1994; 57(4):75-8. PubMed ID: 7950796
    [No Abstract]   [Full Text] [Related]  

  • 12. Calcium channel blockers in the treatment of disease.
    Elmslie KS
    J Neurosci Res; 2004 Mar; 75(6):733-41. PubMed ID: 14994334
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Possibilities of therapeutic applications of neuronal calcium homeostasis].
    Dobrovský K; Valchár M; Höschl C
    Cas Lek Cesk; 1991 Nov; 130(22-23):625-30. PubMed ID: 1664783
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Calcium antagonists for the aging brain].
    Aldenhoff J
    Zahntechnik (Zur); 1991; 48(5):411-3. PubMed ID: 1818467
    [No Abstract]   [Full Text] [Related]  

  • 15. Activators and inactivators of calcium channels: effects in the central nervous system.
    Spedding M; Kilpatrick AT; Alps BJ
    Fundam Clin Pharmacol; 1989; 3 Suppl():3s-29s. PubMed ID: 2559011
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Perspective of calcium antagonist].
    Kim-Mitsuyama S
    Clin Calcium; 2005 Jan; 15(1):81-6. PubMed ID: 15632476
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Pharmacological basis of Ca2+ channels and Ca2+ channel antagonists].
    Adachi-Akahane S
    Clin Calcium; 2005 Oct; 15(10):1589-97. PubMed ID: 16199903
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [The calcium channel blocker--a new addition to the symptomatic therapy of multiple sclerosis].
    Ditzen G; Gerst F; Hänsel W; Koppenhöfer E
    Dtsch Med Wochenschr; 1995 Jul; 120(30):1061-2. PubMed ID: 7628322
    [No Abstract]   [Full Text] [Related]  

  • 19. [Tissue selectivity of calcium channel blockers].
    Godfraind T
    C R Seances Soc Biol Fil; 1998; 192(1):121-35. PubMed ID: 9759358
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Ion channels of vascular smooth muscle and pharmacological effects of calcium antagonists and potassium channel openers].
    Kitamura K; Ogata R
    Fukuoka Igaku Zasshi; 1994 Nov; 85(11):309-13. PubMed ID: 7851831
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.